126 results on '"Habib, Ali A."'
Search Results
2. Would glucocorticoids be approved for clinical use if discovered today?
3. Effectiveness of Eculizumab Treatment by Time from Diagnosis in Patients with Generalized Myasthenia Gravis: A Retrospective Electronic Medical Record Analysis (S15.006)
4. Fixed-cycle and Continuous Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Study Design of ADAPT NXT (P10-11.010)
5. Clinically Meaningful Improvement in Physical Fatigue and Muscle Weakness Fatigability with Rozanolixizumab: Post-hoc Analysis of MG Symptoms PRO Responder Rate in the MycarinG study (P4-11.001)
6. Response to Rozanolixizumab Across Treatment Cycles in Patients with Generalized Myasthenia Gravis: A Post-hoc Analysis (P10-11.005)
7. Drivers of New Rozanolixizumab Treatment Cycles in Patients with Generalized Myasthenia Gravis in the Phase 3 MycarinG and Open-label Extension Studies (P10-11.003)
8. LUMINESCE, a Phase 3 Study of Satralizumab in Generalized Myasthenia Gravis (gMG): Baseline Characteristics (P10-11.015)
9. Treatment Fluctuations in Patients with Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis on Maintenance Ravulizumab Treatment (P10-11.001)
10. The Safety and Efficacy of Chronic Weekly Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis (MG0004) (P4-14.017)
11. Landslide Hazard and Exposure Mapping of Risk Elements in Lower Mandakini Valley, Uttarakhand, India
12. Penambahan Serat Polypropylene Terhadap Kuat Tekan Dan Kuat Tarik Belah Campuran Beton Geopolimer
13. Road Accidents and Safety Measures: A Diverse Study of Ethiopia
14. Hospitalizations and Mortality From Myasthenia Gravis
15. Rozanolixizumab responder and minimal symptom expression rates in generalized myasthenia gravis: Pooled phase 3 and extension studies
16. A Novel Ergonomic Curette Design Reduces Dental Prophylaxis-Induced Muscle Work and Fatigue
17. Development and feasibility testing of an artificially intelligent chatbot to answer immunization-related queries of caregivers in Pakistan: A mixed-methods study
18. The role of the islamic culture courses in enhancing the intellectual security among PSAU students
19. Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
20. Guillain-Barré Syndrome
21. Therapeutic Plasma Exchange Versus FcRn Inhibition in Autoimmune Disease
22. Refractory myasthenia gravis: the more we learn, the less we know.
23. Effect of Foliar Application of Boron, Zinc and Manganese on Growth, Yield and Oil Contents of Sunflower (Helianthus annuus L.)
24. Advancements in Targeted Therapies for Generalized Acetylcholine Receptor Antibody Positive Myasthenia Gravis: Beginnings of a Paradigm Shift
25. 2634 Cyclical rozanolixizumab treatment in generalised myasthenia gravis (gMG): pooled analysis of MycarinG (Phase 3 study) and two open-label extension studies
26. A multidisciplinary assessment of ChatGPTs knowledge of amyloidosis
27. Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
28. Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO
29. Kidney, Adrenal Gland, and Paraganglia
30. Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs
31. Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO
32. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
33. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
34. Molecular Characterization of Germin-like Protein Genes in Zea mays (ZmGLPs) Using Various In Silico Approaches
35. Ravulizumab for the Treatment of Generalized Myasthenia Gravis: Timing of Response (P1-5.004)
36. Long-term Efficacy and Safety of Symptom-driven Cyclic Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis: A Pooled Analysis of a Phase 3 Study and Two Open-label Extension Studies (P1-5.012)
37. Characterization of Polyneuropathy in Patients Receiving Enfortumab Vedotin for the Treatment of Metastatic Urothelial Carcinoma (P14-8.010)
38. Comorbidities in patients with myasthenia gravis in the USA: a retrospective claims database analysis (P1-5.003)
39. Efficacy of Rozanolixizumab in Generalized Myasthenia Gravis: Subgroup Analyses from the Randomized Phase 3 MycarinG Study (S5.007)
40. Clinical Experience With Efgartigimod For Treatment Of Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis (P1-8.004)
41. Patient Support Program Enhancements In Patients Diagnosed With Generalized Myasthenia Gravis Facing Social Determinants of Health Challenges (P4-9.006)
42. Ferroptosis in Haematological Malignancies and Associated Therapeutic Nanotechnologies
43. Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials
44. Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial
45. Outcomes After Percutaneous Tracheostomy in Patients with COVID-19: A Single-Center Series of 377 Cases
46. The role of intimate partner relationships on suicide risk among men in the construction sector in New Zealand (NZ): Understanding the interplay between work, family, and employee mental health
47. TREATMENT OF RADIOACTIVE LIQUID WASTE USING SUN HEAT
48. The optimal approach of EBUS-FNA rapid on-site evaluation (ROSE): a five-year experience from a large academic medical center
49. Patient preference for virtual versus in‐person visits in neuromuscular clinical practice
50. Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.